Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Droxidopa capsules in the strengths of 100 mg, 200 mg and 300 mg, Aurobindo Pharma said in a regulatory filing. The company said the product will be launched immediately.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ku5qm7
via IFTTT